Robeco Institutional Asset Management B.V. Acquires 30,902 Shares of MetLife, Inc. $MET

Key Points

• Robeco Institutional Asset Management increased its stake in MetLife by 69.4%, acquiring 30,902 shares in Q4 to hold 75,443 shares worth about $5.955 million.
• Institutional investors collectively own 94.99% of MetLife's stock, with several other funds modestly growing their positions in recent quarters.
• MetLife beat quarterly EPS estimates ($2.49 vs. $2.34) and posted a 27.6% YoY revenue gain, while analysts maintain a consensus "Moderate Buy" with a consensus price target of $93.38.

Robeco Institutional Asset Management B.V. raised its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 69.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 75,443 shares of the financial services provider's stock after acquiring an additional 30,902 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in MetLife were worth $5,955,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Blue Trust Inc. raised its holdings in MetLife by 3.6% during the 3rd quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider's stock valued at $295,000 after acquiring an additional 125 shares during the period. Trustmark Bank Trust Department grew its position in shares of MetLife by 4.6% during the 3rd quarter. Trustmark Bank Trust Department now owns 2,870 shares of the financial services provider's stock valued at $236,000 after purchasing an additional 127 shares in the last quarter. Daymark Wealth Partners LLC grew its position in shares of MetLife by 4.2% during the 3rd quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider's stock valued at $263,000 after purchasing an additional 130 shares in the last quarter. Cornerstone Wealth Group LLC grew its position in shares of MetLife by 4.9% during the 3rd quarter. Cornerstone Wealth Group LLC now owns 2,790 shares of the financial services provider's stock valued at $230,000 after purchasing an additional 130 shares in the last quarter. Finally, UMB Bank n.a. grew its position in shares of MetLife by 1.9% during the 3rd quarter. UMB Bank n.a. now owns 7,040 shares of the financial services provider's stock valued at $580,000 after purchasing an additional 132 shares in the last quarter. Institutional investors own 94.99% of the company's stock.

Key Headlines Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife told shareholders to reject a mini‑tender offer from Potemkin Limited — the company framed the unsolicited $44.20 bid as opportunistic and well below market, signaling active management protection of shareholder value. MetLife Recommends Shareholders Reject “Mini‑Tender” Offer by Potemkin Limited
• Positive Sentiment: Concert bookings at MetLife Stadium (e.g., Usher & Chris Brown two‑night event) keep venue utilization and non‑insurance revenue opportunities visible to investors. Usher and Chris Brown bring the 'R&B Tour' to MetLife for two‑night event
• Positive Sentiment: MetLife Foundation awarded over $6.5M globally, reinforcing ESG/PR initiatives that can support brand and stakeholder relations. MetLife Foundation Awards Over $6.5 Million Globally to Address Essential Community Needs
• Neutral Sentiment: MetLife Stadium is being temporarily rebranded for the 2026 FIFA World Cup (New York‑New Jersey Stadium), increasing global visibility but with unclear direct financial impact on MetLife the insurer. MetLife Stadium temporarily changes its name for World Cup
• Negative Sentiment: Broad negative press about planned NJ Transit fare surges to MetLife Stadium for World Cup events (reports of $80–$100+ one‑way fares) has drawn political pushback from leaders and could create reputational and logistical headaches for stadium events. That controversy can translate into headline risk for MetLife’s stadium association. Trumpflation hits the World Cup: Fans face $80–$100 transit fares on top of $4,000‑plus tickets
• Negative Sentiment: Political leaders including Chuck Schumer and Kathy Hochul publicly criticized high train fares and urged that transport costs be covered, amplifying the negative publicity tied to World Cup logistics at MetLife Stadium. Chuck Schumer, Kathy Hochul Slam FIFA For $100 Train Tickets To MetLife Stadium, Urge Covering Transport For Fans Amid '$11 Billion Windfall'
• Negative Sentiment: Bank of America trimmed its price target on MET from $103 to $99 (still a Buy rating), which can exert near‑term selling pressure despite the remaining upside the analyst sees. MetLife NYSE: MET Price Target Cut to $99.00 by Analysts at Bank of America

MetLife Stock Performance

NYSE MET opened at $77.55 on Thursday. The company has a 50-day simple moving average of $73.07 and a two-hundred day simple moving average of $76.88. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $83.85. The firm has a market cap of $50.57 billion, a price-to-earnings ratio of 16.50, a PEG ratio of 0.68 and a beta of 0.74.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion during the quarter, compared to analyst estimates of $31.43 billion. During the same period in the prior year, the business posted $2.08 earnings per share. The company's revenue was up 27.6% on a year-over-year basis. On average, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Keefe, Bruyette & Woods restated a "moderate buy" rating and set a $87.00 price target on shares of MetLife in a research report on Thursday, March 26th. UBS Group boosted their price target on shares of MetLife from $98.00 to $102.00 and gave the company a "buy" rating in a research report on Thursday, April 9th. Wells Fargo & Company reduced their price target on shares of MetLife from $93.00 to $90.00 and set an "overweight" rating for the company in a research report on Friday, April 10th. Barclays reduced their price target on shares of MetLife from $92.00 to $89.00 and set an "overweight" rating for the company in a research report on Wednesday, April 8th. Finally, Bank of America reduced their price target on shares of MetLife from $103.00 to $99.00 and set a "buy" rating for the company in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.38.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.